Publications by authors named "Richard M Simon"

Claim this Profile
I
Inappropriate censoring in Kaplan-Meier analyses.
Tito Fojo, Richard M Simon

Lancet Oncol· October 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Phase 2 study of pembrolizumab in patients with advanced rare cancers.
Aung Naing, Funda Meric-Bernstam, Bettzy Stephen, Daniel D Karp, Joud Hajjar, Richard M Simon

J Immunother Cancer· March 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Identification of pharmacodynamic biomarkers and common molecular mechanisms of response to genotoxic agents in cancer cell lines.
Dong-Joon Min, Yingdong Zhao, Anne Monks, Alida Palmisano, Curtis Hose, Richard M Simon

Cancer Chemother Pharmacol· October 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
D3Oncoprint: Stand-Alone Software to Visualize and Dynamically Explore Annotated Genomic Mutation Files.
Alida Palmisano, Yingdong Zhao, Richard M Simon

JCO Clin Cancer Inform· December 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
O
On the Design of Combination Cancer Therapy.
James H Doroshow, Richard M Simon

Cell· December 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
O
OpenGeneMed: a portable, flexible and customizable informatics hub for the coordination of next-generation sequencing studies in support of precision medicine trials.
Alida Palmisano, Yingdong Zhao, Ming-Chung Li, Eric C Polley, Richard M Simon

Brief Bioinform· September 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Amount, Source, and Quality of Support as Predictors of Women's Birth Evaluations.
Richard M Simon, Katherine M Johnson, Jessica Liddell

Birth· September 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Efficiency of Prostate Cancer Diagnosis by MR/Ultrasound Fusion-Guided Biopsy vs Standard Extended-Sextant Biopsy for MR-Visible Lesions.
M Minhaj Siddiqui, Arvin K George, Rachel Rubin, Soroush Rais-Bahrami, Howard L Parnes, Richard M Simon

J Natl Cancer Inst· September 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Analytical Validation and Application of a Targeted Next-Generation Sequencing Mutation-Detection Assay for Use in Treatment Assignment in the NCI-MPACT Trial.
Chih-Jian Lih, David J Sims, Robin D Harrington, Eric C Polley, Yingdong Zhao, Richard M Simon

J Mol Diagn· January 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Clinical implications of a multiparametric magnetic resonance imaging based nomogram applied to prostate cancer active surveillance.
M Minhaj Siddiqui, Hong Truong, Soroush Rais-Bahrami, Lambros Stamatakis, Jennifer Logan, Richard M Simon

J Urol· June 2015

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
U
Use of serial multiparametric magnetic resonance imaging in the management of patients with prostate cancer on active surveillance.
Annerleim Walton Diaz, Nabeel Ahmad Shakir, Arvin K George, Soroush Rais-Bahrami, Baris Turkbey, Richard M Simon

Urol Oncol· May 2015

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Randomized Trial of Oral Cyclophosphamide and Veliparib in High-Grade Serous Ovarian, Primary Peritoneal, or Fallopian Tube Cancers, or BRCA-Mutant Ovarian Cancer.
Shivaani Kummar, Amit M Oza, Gini F Fleming, Daniel M Sullivan, David R Gandara, Richard M Simon

Clin Cancer Res· April 2015

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Application of molecular profiling in clinical trials for advanced metastatic cancers.
Shivaani Kummar, P Mickey Williams, Chih-Jian Lih, Eric C Polley, Alice P Chen, Richard M Simon

J Natl Cancer Inst· April 2015

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
G
GeneMed: An Informatics Hub for the Coordination of Next-Generation Sequencing Studies that Support Precision Oncology Clinical Trials.
Yingdong Zhao, Eric C Polley, Ming-Chung Li, Chih-Jian Lih, Alida Palmisano, Richard M Simon

Cancer Inform· April 2015

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Diagnostic value of biparametric magnetic resonance imaging (MRI) as an adjunct to prostate-specific antigen (PSA)-based detection of prostate cancer in men without prior biopsies.
Soroush Rais-Bahrami, M Minhaj Siddiqui, Srinivas Vourganti, Baris Turkbey, Ardeshir R Rastinehad, Richard M Simon

BJU Int· March 2015

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Comparison of MR/ultrasound fusion-guided biopsy with ultrasound-guided biopsy for the diagnosis of prostate cancer.
M Minhaj Siddiqui, Soroush Rais-Bahrami, Baris Turkbey, Arvin K George, Jason Rothwax, Richard M Simon

JAMA· January 2015

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Is the "3+3" dose-escalation phase I clinical trial design suitable for therapeutic cancer vaccine development? A recommendation for alternative design.
Osama E Rahma, Emily Gammoh, Richard M Simon, Samir N Khleif

Clin Cancer Res· September 2014

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Considerations for the successful co-development of targeted cancer therapies and companion diagnostics.
Jane Fridlyand, Richard M Simon, Jessica C Walrath, Nancy Roach, Richard Buller

Nat Rev Drug Discov· October 2013

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Criteria for the use of omics-based predictors in clinical trials.
Lisa M McShane, Margaret M Cavenagh, Tracy G Lively, David A Eberhard, William L Bigbee, Richard M Simon

Nature· October 2013

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Criteria for the use of omics-based predictors in clinical trials: explanation and elaboration.
Lisa M McShane, Margaret M Cavenagh, Tracy G Lively, David A Eberhard, William L Bigbee, Richard M Simon

BMC Med· October 2013

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Accuracy of multiparametric magnetic resonance imaging in confirming eligibility for active surveillance for men with prostate cancer.
Lambros Stamatakis, M Minhaj Siddiqui, Jeffrey W Nix, Jennifer Logan, Soroush Rais-Bahrami, Richard M Simon

Cancer· September 2013

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The exomes of the NCI-60 panel: a genomic resource for cancer biology and systems pharmacology.
Ogan D Abaan, Eric C Polley, Sean R Davis, Yuelin J Zhu, Sven Bilke, Richard M Simon

Cancer Res· July 2013

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
H
How to develop treatments for biologically heterogeneous "diseases".
Richard M Simon

Clin Cancer Res· August 2012

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
G
Gendered contexts: masculinity, knowledge, and attitudes toward biotechnology.
Richard M Simon

Public Underst Sci· May 2011

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
G
Gender differences in knowledge and attitude towards biotechnology.
Richard M Simon

Public Underst Sci· November 2010

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis